Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: California

UCI Heads Study Investigating NeuroRX’s ZYESAMI™ (aviptadil) Investigating Ability to Reduce Progression to Critical COVID-19

During the pandemic, TrialSite has reported multiple times on the potential for NeuroRX’s RLF-100 (aviptadil) currently under investigation and accessible […]

UCI Heads Study Investigating NeuroRX’s ZYESAMI™ (aviptadil) Investigating Ability to Reduce Progression to Critical COVID-19
4 weeks ago
Share

UCLA Leading Statewide Effort to Open Up Communities at Risk for Vaccination & Treatment

Led by the University of California, Los Angeles (UCLA), a coalition of 11 academic institutions and their community partners across […]

UCLA Leading Statewide Effort to Open Up Communities at Risk for Vaccination & Treatment
2 months ago
Share

Hoag Brings Groundbreaking Cancer Treatment Technology to Orange County

Hoag Memorial Hospital Presbyterian became the only hospital in Orange County, and one of the first in the nation, to provide […]

Hoag Brings Groundbreaking Cancer Treatment Technology to Orange County
3 months ago
Share

Advanced Monoclonal Antibody Clinical Trial Targeting COVID-19 Comes to California’s Imperial Valley

Imperial County’s El Centro Regional Medical Center (ECRMC) will be participating in yet another clinical trial battling COVID-19. The health […]

Advanced Monoclonal Antibody Clinical Trial Targeting COVID-19 Comes to California’s Imperial Valley
5 months ago
Share

A Small Research Site in Rural NorCal Selected by Moderna & Pfizer/BioNTech for Phase 3 COVID-19 Vaccine Trials

Paradigm Clinical Research Centers Inc. (Paradigm Research) in Redding, California, was selected to participate in both the Moderna mRNA-1273 and […]

A Small Research Site in Rural NorCal Selected by Moderna & PfizerBioNTech for Phase 3 COVID-19 Vaccine Trials
8 months ago
Share

Will Clinical Research Grow in California’s Capital?

Just as the death toll from COVID-19 rose over 90,000 in the United States, Operation Warp Speed was announced by […]

Will Clinical Research Grow in California’s Capital
10 months ago
Share

Research-as-a-Care Option Vendor Joins California & Verily in Project Baseline COVID-19 Initiative

Elligo Health Research, a Texas-based research organization emphasizing models supporting clinical research-as-a-care-option, has inked an alliance with health data specialists Verily […]

Research-as-a-Care Option Vendor Joins California & Verily in Project Baseline COVID-19 Initiative
10 months ago
Share

Some Data Points Lead to Possible Good Signs for Remdesivir, but Still Too Early to Tell

A growing number of healthcare professionals become optimistic about Gilead’s remdesivir as a possible treatment to at least slow down […]

Some Data Points Lead to Possible Good Signs for Remdesivir, but Still Too Early to Tell
11 months ago
Share

Cedars-Sinai Enrolling Hospitalized COVID-19 Patients to Assess Use of Remdesivir Against COVID-19

Cedars-Sinai, Los Angeles is actively participating in the remdesivir clinical trial as an experimental class of treatment for COVID-19. The […]

Cedars-Sinai Enrolling Hospitalized COVID-19 Patients to Assess Use of Remdesivir Against COVID-19
11 months ago
Share

Some University of California Professors Regularly Profit from Conflicts of Interest, Shortchanging University and State Taxpayers

California has had some of the nation’s most rigorous conflict of interest rules for public employees, from annual reporting to caps […]

Some University of California Professors Regularly Profit from Conflicts of Interest, Shortchanging University and State Taxpayers
1 year ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.